UBS Maintains Neutral on Cabot, Lowers Price Target to $86
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $92 to $86.
Stocks · News reference
UBS Maintains Neutral on Cabot, Lowers Price Target to $92
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $97 to $92.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cabot Reports Q3 2026 Results: Full Earnings Call Transcript
Cabot (NYSE:CBT) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Cabot Announces Modified $50M Department Of Energy Grant Plus About $75M Of Its Own Investment To Expand Battery Materials Production In Franklin, Louisiana And Pampa, Texas; Redirects Funding From Michigan Project, Operational By End Of 2028
8-K filing — CABOT CORP (CBT)
Filed: 2026-09-15 AccNo: 0001193125-26-391407 Size: 160 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits